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1607-551X/Copyright ª 2015, KaohsiuAbstract The aim of this study was to explore clinical features of renal infarction (RI) that
may have a role in diagnosis and treatment in our patient cohort and provide data on midterm
renal functions. Medical records of patients with diagnosis of acute RI, established by contrast
enhanced computed tomography (CT) and at least 1 year follow-up data, who were hospital-
ized in our clinic between 1998 and 2012 were retrospectively reviewed; including descriptive
data, clinical signs and symptoms, etiologic factors, laboratory findings, and prescribed treat-
ments. Patients with solitary infarct were treated with acetylsalicylic acid (ASA) only, whereas
patients with atrial fibrillation (AF) or multiple or global infarct were treated with anticoagu-
lants. Estimated Glomerular Filtration Rate (eGFR) referring to renal functions was determined
by the Modification of Diet in Renal Disease (MDRD) formula. Twenty-seven renal units of 23
patients with acute RI were identified. The mean age was 59.7  15.7 years. Fourteen patients
(60.8%) with RI had atrial fibrillation (AF) as an etiologic factor of which four had concomitant
mesenteric ischemia at diagnosis. At presentation, 20 patients (86.9%) had elevated serum
lactate dehydrogenase (LDH), 18 patients (78.2%) had leukocytosis, and 16 patients (69.5%)
had microscopic hematuria. Two patients with concomitant mesenteric ischemia and AF
passed away during follow up. Mean eGFR was 70.8  23.2 mL/min/1.73 m2 at admission
and increased to 82.3  23.4 mL/min/1.73 m2 at 1 year follow up. RI should be considered
in patients with persistent flank or abdominal pain, particularly if they are at high risk of
thromboembolism. Antiplatelet and/or anticoagulant drugs are both effective treatment op-
tions according to the amplitude of the infarct for preserving kidney functions.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
t of Urology, SB Siverek State Hospital, Siverek-Sanliurfa Highway thirteenth kilometer, Sanliurfa,
il.com (S. Ongun).
5.07.005
ng Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
530 S. Ongun et al.IntroductionTable 1 Characteristics and clinical manifestations of
patients with renal infarction.
Characteristics and clinical manifestation
Age (y) 59.7  15.7
Male/female 12/11
Body mass index (kg/m2) 29.5  5.4
Abdominal pain 13 (56.5)
Flank pain 10 (43.4)
Nausea 7 (30.4)
Vomiting 5 (21.7)
Abdominal tenderness 18 (78.2)
Fever 3 (13.0)
Costovertebral angle tenderness 11 (47.8)
Data are presented as n (%) or mean  SD, unless otherwise
indicated.Renal infarction (RI) is usually misdiagnosed at the initial
presentation of patients because of its rarity, so high sus-
picion is of utmost importance for early diagnosis. It is
often mimicked by other more common conditions such as
urolithiasis, lower back pain caused by lumbar disc hernia
or spinal stenosis, and acute abdomen. Incidence of RI was
reported as four to seven cases in 100,000 of emergency
department visits [1,2]. Most common causes of RI are
traumatic, thromboembolic, atheroembolic, and throm-
botic conditions [2]. Most of the published articles on this
topic are mainly based on case series [1,3e5]. Some labo-
ratory parameters such as elevated serum lactate dehy-
drogenase (LDH) levels, microscopic hematuria and
impaired renal functions described by elevated serum
creatinine levels are the most encountered findings
accompanying acute abdominal or flank pain in one of the
largest series reported by Hazanov et al [5]. Considering
diagnostic imaging, contrast-enhanced computed tomog-
raphy (CT) seems the most appropriate method for evalu-
ating patients suspected of having RI, furthermore renal
isotope scans or renal angiography may help in doubtful
cases [1e3,5]. Thrombolytic, anticoagulant and anti-
aggregant therapies have been used in previous reports
[1e5]. Despite absence of clear-cut recommendations for
management of the condition, it is not anticipated to be
discrete from the common approach to thromboembolic
events. The above-mentioned studies mainly focus on
diagnostic scheme and acute management of these patients
whereas detailed long-term follow-up data regarding renal
functions are missing in most series. Thus, we aimed to
evaluate the diagnostic and therapeutic management of
patients and provide data especially on mid-term renal
functions of patients who were hospitalized in our clinic
with acute RI.
Methods
Medical records of all patients who were hospitalized and
treated in our department with the definitive diagnosis of
acute RI confirmed by CT and with at least 1 year follow-up
data between 1998 and 2012 were retrospectively
reviewed. We diagnosed RI on the basis of CT scan
appearance. A renal infarct was defined as a peripheral
triangle-shaped area in the renal parenchyma which was
slightly hypodense on unenhanced scans using predefined
display window settings for soft tissues [20e40 Hounsfield
units (HU)], and which showed no contrast enhancement
[6]. Descriptive data, medical history, comorbid conditions,
clinical signs and symptoms, complete blood count (CBC),
biochemical analysis, urinalysis, and CT findings at admis-
sion were evaluated. In our institution, 100 mg acetylsali-
cylic acid (ASA) is used to treat solitary infarcts in those
without atrial fibrillation (AF). We use intravenous or sub-
cutaneous heparin followed by oral warfarin to treat pa-
tients with bilateral, multiple, or global infarcts and those
with AF.
Estimated Glomerular filtration rate (eGFR) was calcu-
lated according to the Modification of Diet in Renal Disease
(MDRD) formula both at admission and also at 1 month and 1year follow up [7]. Data were analyzed using descriptive
statistics.Results
A total of 23 patients (12 male) were included in the study.
Their mean age was 59.7  15.7 years. Their body mass
index was 29.5  5.4 kg/m2. Further details of character-
istics and clinical manifestations of patients are given in
Table 1. At presentation, 14 patients (61%) had AF, 12 pa-
tients (52%) had hypertension, and four patients (17%) had
mesenteric ischemia. At the time of admission, 13 patients
(56.5%) had abdominal pain and 10 patients (43.4%) had
flank pain. In addition to abdominal or flank pain, seven
individuals (30.4%) reported nausea, and five individuals
(21.7%) had vomited. On examination, 18 patients (78.2%)
had abdominal tenderness, 11 patients (47.8%) had costo-
vertebral tenderness, and three patients (13%) were
febrile.
By CT scan, left kidney RI was diagnosed in 10 patients
(43.4%), right kidney RI in nine patients (39.1%) and bilat-
eral RI in four patients (17.3%). Consequently, a total of 27
kidneys had areas of RI. Ten kidneys (37%) had a solitary
area of infarction (Figure 1), eight kidneys (29.6%) had
multiple areas of infarction (Figure 2), and nine kidneys
(33.3%) were globally infarcted. Elevated LDH levels were
the most frequent abnormal finding in 73.9% of patients at
admission and in 86.9% of patients 24 hours after admission.
Detailed analyses of laboratory findings are provided in
Table 2. Fourteen patients had atrial fibrillation (AF); 12
patients had hypertension, and four patients had concom-
itant mesenteric ischemia at diagnosis. Among these pa-
tients with AF, 11 of them had multiple infarcts or global
infarction of kidney. Considering the four patients with
concomitant mesenteric ischemia; three of them had
bilateral RI and two of them passed away during the
following month. The first patient who passed away was a
69-year-old male who presented with abdominal pain,
nausea, and vomiting. He had abdominal tenderness on
physical examination, his eGFR was 55 mL/min/1.73 m2,
and he had AF. He expired on the 4th day of his hospitali-
zation. The second patient who passed away was a 66-year-
Figure 1. A solitary infarct in the left kidney (indicated by
arrow).
Figure 2. Multiple infarctions in the right kidney (indicated
by arrows).
Table 2 Laboratory findings of patients hospitalized with the d
Laboratory data
(normal ranges)




LDH (125e243 U/L) 17/23 (73.9) 20/23
WBC (4e10 103/mL) 15/23 (65.2) 18/23
CK (29e168 U/L) 8/23 (34.7) 14/23
AST (5e34 U/L) 14/23 (60.8) 16/23
ALT (0e55 U/L) 8/23 (34.7) 9/23
ALP (40e150 U/L) 8/23 (34.7) 10/23
CRE (0.6e1.1 mg/dL) 7/23 (30.4) 7/23
Hematuria (>3) 12/23 (52.1) 16/23
ALP Z alkaline phosphatase; ALT Z alanine aminotransferase;
CRE Z serum creatinine; LDH Z lactate dehydrogenase; WBC Z whi
Midterm renal functions after renal infarction 531old male, he also presented with abdominal pain, nausea,
and vomiting. He had abdominal tenderness on physical
examination, his eGFR was 81 mL/min/1.73 m2, and he
expired on the 3rd day of his hospitalization. None of the
patients with solitary infarct (5/23) had impaired renal
function on admission. Their mean age was 43.8  13.1
years. The mean age of the 18 patients with AF and bilat-
eral infarcts, multiple infarcts, or global infarction was
64.1  13.5 years. Eight of them had impaired renal func-
tion (eGFR < 60 mL/min/1.73 m2) at admission. eGFR
increased above 60 mL/min/1.73 m2 in three patients with
impaired renal function at 1 month follow up. Five patients
remained with impaired renal function at 1 month and 1
year follow up, however no requirement of dialysis was
indicated for these patients. The mean age of these five
patients, three of them female, was 75  9.1 years; body
mass index (BMI) was 33.6  4.9 kg/m2. Four of them pre-
sented with abdominal pain, one with flank pain; and one
felt nausea. All had abdominal tenderness. All of the five
patients with remaining impaired renal function had
elevated LDH, creatine kinase (CK) and alkaline phospha-
tase (ALP) on admission; three of the five had an elevated
white blood cell count (WBC), four of them had elevated
aspartate aminotransferase (AST) and alanine aminotrans-
ferase (ALT) at admission.Discussion
We shared our 15 years’ experience with 23 RI patients
treated in our clinic. Abdominal or flank pain are the most
frequent symptoms and are usually accompanied by vom-
iting, nausea, and fever [3]. All of the patients in our series
also had abdominal or flank pain. After the elimination of
the most common diseases with this presentation, RI should
be remembered in the differential diagnosis. RI occurred at
almost the same ratio between the right and left kidney
(39e43%) in our patient cohort. It has been postulated
previously that RI occurs in the left kidney more often
because of the fact that the left renal artery forms an acute
angle with the aorta [8]. However more recent case series
also report that occurrence rates for left and right kidney
are similar [9].
Serum LDH elevation is a marker for cell necrosis and





Median levels 24 h
after admission
(86.9) 691 (210e1050) 958 (508e1523)
(78.2) 12.9 (8.7e17.2) 13.5 (12.1e16.9)
(60.8) 47 (28e77) 296 (52e639)
(69.5) 35 (25e52) 47 (28e77)
(39.1) 44 (21e68) 45 (23e77)
(43.4) 99 (82e189) 108 (86e200)
(30.4) 0.95 (0.83e1.20) 0.95 (0.84e1.22)
(69.5) d d
AST Z aspartate aminotransferase; CK Z creatinine kinase;
te blood cell count.
532 S. Ongun et al.symptoms in patients with RI [9]. If there is a high clinical
suspicion of acute RI, serum LDH should be repeated 24
hours after admission since normal values at admission may
increase, as in our patient cohort. Patients with RI have
hematuria (54e100%) and elevated LDH [5,10]. Over 80% of
the patients with RI have pain, elevated LDH, and pro-
teinuria and/or hematuria [3]. In our series 86.9% of pa-
tients had elevated LDH and 69.5% of patients had
hematuria. 65% of them had pain, elevated LDH, and he-
maturia. Serum LDH is strongly suggestive of RI but we know
that it cannot make an accurate diagnosis for RI. Contrast-
enhanced CT is still the gold standard for the diagnosis of RI
[6]. We believe that serum LDH may help to consider RI in
differential diagnosis and lead to a further evaluation with
contrast-enhanced CT.
Most patients with RI have a high risk history of throm-
boembolism. It was noted in the literature that most pa-
tients with RI had AF, hypertension, valvular disease,
ischemic heart disease, or coagulation abnormalities, sug-
gesting at least one thromboembolic risk factor [5]. AF and
hypertension were also found to be the most frequent risk
factors for RI in our patients concordant with previous
reports.
Acute mesenteric ischemia is usually lethal and has high
mortality rates ofw60e80% [11]. The majority of cases are
misdiagnosed because the role of current radiographic and
noninvasive modalities is limited in the early diagnosis of
acute mesenteric ischemia. CT scans may reveal bowel wall
thickening, ascites, or occlusion of the mesenteric arterial
trunk. But, those signs are nonspecific and usually found
only in the late stage of mesenteric ischemia [12]. Two out
of four patients with concomitant mesenteric ischemia
passed away during the 1 month follow up in our patient
cohort. Three of them had bilateral RI. Because of the high
mortality of mesenteric ischemia, if clinical signs of
mesenteric ischemia are found after the diagnosis of RI,
further investigation should be carried out. As seen in our
series, determination of concomitant mesenteric ischemia
has usually been accompanied by bilateral renal infarction.
Mesenteric ischemia should be kept in mind if the patient
has bilateral RI.
No proven therapeutic guidelines for the treatment of RI
have been established. The therapeutic options include
medical therapy and operative revascularization. Previous
studies have shown that medical therapy is as effective as
surgical therapy [8,13,14]. Medical therapy can be intra-
arterial thrombolytic therapy, anticoagulation, and ASA
[3,5,10]. However, these options depend on the duration of
symptoms. Thrombolytic therapy was found to be better if
used within 90e180 minutes while the renal tissue is still
viable, but nearly all diagnoses of RI are made after the first
24 hours [9]. Early diagnosis enables more effective ther-
apeutic intervention. In the cases presented here, the pa-
tients who had AF, global infarction, multiple infarctions,
or bilateral infarction were treated with low molecular
weight heparin or intravenous heparin and warfarin to bring
their anticoagulation into the therapeutic range. The pa-
tients with solitary infarct in the kidney and with no AF
were treated with 100 mg of oral ASA. In addition, because
these patients are also at a high risk for further thrombo-
embolisms, long-term anticoagulation is mandatory. No
additional thromboembolic event was seen in our patients.Regarding studies reporting evaluation of renal functions
on follow up, Huang et al [3] gave the 1 year follow up of
four patients with impaired renal function at admission,
concluding that none of those patients required dialysis.
Twenty percent of their patients had impaired renal func-
tion at admission which is lower than our 34.7% rate.
However, they do not provide detailed information about
renal functions. A more recent report by Bourgault et al [9],
which has been the largest case series on this topic to date
(nZ 94), mentioned that 40.4% (38/94) of the patients had
impaired renal functions of whom seven required hemodi-
alysis at initial presentation and three developed end stage
renal disease. No patient required dialysis in our cohort at
admission or at 1 year follow up. In a recent study Bae et al
[15] presented the effects of RI on renal functions and most
of the patients recovered spontaneously. Our study is the
first providing data regarding midterm renal functions for
the Turkish patient population. We demonstrate that renal
functions continue to heal in all patients with renal infarct
under antiplatelet and anticoagulant therapies through 1
year follow up.
Our study had several important limitations. First, it was
a retrospective study using a database and the medical
records of the patients; only patients with available results
were enrolled. Second, the number of the patients with RI
was limited. Furthermore; clinical approach, availability of
diagnosis, and treatment options as well as clinical
awareness of the disease may vary over 15 years.
A high index of clinical suspicion is needed and this is
the key of early diagnosis; RI should be taken into
consideration for differential diagnosis in patients with a
high risk of thromboembolism, persistent flank or abdom-
inal pain, elevated serum LDH, and hematuria. Contrast-
enhanced CT should be performed immediately to
demonstrate or rule out RI. If patients have AF and bilat-
eral RI, there might be an increased risk of concomitant
mesenteric ischemia. Patients with solitary infarct in the
kidney and with no AF can be safely treated with 100 mg
ASA to prevent recurrent thromboembolic events and
preserve renal functions.References
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